RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-967
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0314200; Gene model (P.falciparum): PF3D7_0217500; Gene product: calcium-dependent protein kinase 1 (cdpk1)
Details mutation: The mutant contains a FRTed ORF of the cdpk1 locus
Details conditional mutagenesis: The ORF of cdpk1 is removed in the sporozoite stage by the Flp/FRT system
Transgene
Transgene not Plasmodium: FlpL recombinase of yeast (FlpL)
Promoter: Gene model: PBANKA_1349800; Gene model (P.falciparum): PF3D7_1335900; Gene product: thrombospondin-related anonymous protein | sporozoite surface protein 2 (TRAP; SSP2; SSP-2)
3'UTR: Gene model: PBANKA_1349800; Gene product: sporozoite surface protein 2 thrombospondin-related anonymous protein (sporozoite surface protein 2; SSP2; SSP-2)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
PhenotypeNo phenotype has been described
Last modified: 24 November 2013, 13:22
  *RMgm-967
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 24265753
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherS. Jebiwott, P. Bhanot
Name Group/DepartmentDepartment of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jerse
Name InstituteRutgers New Jersey Medical School, Rutgers, The State University of New Jersey
CityNewark, New Jersey
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-967
Principal nameCDPK1 cKO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant is a 'Flp/FRT conditional knock-out mutant' of cdpk1. The mutant expresses the yeast FlpL recombinase under the control of the trap promoter  and contains a FRTed ORF (open reading frame) of the cdpk1 locus. 

This mutant has been generated by replacement of the endogenous cdpk1 gene by an cdpk1 gene with a FRTed ORF in the mutant RMgm-747 that expresses FlpL. This mutant expresses the yeast FlpL recombinase under the control of the promoter of trap and does not contain a selectable marker. The flpl gene is integrated into the silent 230p locus by double cross-over integration.

The cdpk1 ORF is removed from the genome by using the Flp/FRT site-specific recombination (SSR) system (see RMgm-269, RMgm-747). Removal of the FRTed ORF of cdpk1  has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the FlpL recombinase in sporozoites that resulted in the excision of the ORF of cdpk1 which was flanked by FRT sequences.

Protein (function)
In malaria parasites, intracellular Ca2+ signals are translated into stage-specific cellular responses by members of a family of Ca2+-dependent protein kinases (CDPKs), which combine an N-terminal kinase domain with a C-terminal, calmodulin-like regulatory domain in the same polypeptide. By analysis of a promoter-swap mutant that expresses CDPK1 only in asexual blood stages and not in gametocytes and ookinetes it has been shown that CDPK1 plays an essential role in ookinete formation (see RMgm-773; RMgm-966).

Phenotype
The Flp/FRT site-specific recombination (SSR) system of yeast has been used to silence CDPK1 expression specifically in liver stages. Removal of the FRTed ORF of cdpk1  has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the FlpL recombinase in sporozoites that resulted in the excision of the FRTed ORF of cdpk1.

The efficiency of 'slincing' CDPK1 expression (i.e. the efficiency of excision of the cdpk1 gene) has (only) been analysed by PCR analysis of parasites recovered after mosquito transmission.

Equal numbers of sporozoites were recovered from salivary glands of CDPK1 cKO-infected and FlpL/TRAP-infected mosquitoes, demonstrating that CDPK1 is not required for parasite invasion of salivary glands. To determine if CDPK1 plays a role in hepatocyte invasion, CDPK1 cKO sporozoites were used to infect the human hepatoma cell line, HepG2. FlpL/TRAP sporozoites were used as controls in this and subsequent experiments. There was no significant difference in the number of liver stages formed by CDPK1 cKO or control sporozoites. These results demonstrate that CDPK1 is not essential for the parasite’s invasion of hepatocytes or subsequent intrahepatic development. To study CDPK1’s role in parasite egress from infected HepG2 cells, the number of extracellular merosomes released in CDPK1 cKO and control infected HepG2 cultures was determined. There was no significant difference in the number of merosomes present in both. These results indicate that CDPK1 is not essential for parasite development in and egress from hepatocytes.

Additional information
See also RMgm-518 and RMgm-966 for unsuccessful and successful attempts to select for mutants that lack expression of CDPk1


Other mutants
RMgm-518: unsuccessful attempts to disrupt cdpk1
RMgm-966: A mutant lacking expression of CDPK! (successful disruption of cdpk1!)
RMgm-773: A promoter exchange mutant that expresses CDPK1 under control of the the asexual blood stage specific clag promoter
RMgm-772: A mutant expressing CDPK1-GFP from the endogenous cdpk1


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0314200
Gene Model P. falciparum ortholog PF3D7_0217500
Gene productcalcium-dependent protein kinase 1
Gene product: Alternative namecdpk1
Details of the genetic modification
Short description of the mutationThe mutant contains a FRTed ORF of the cdpk1 locus
Inducable system usedFlp/FRT
Short description of the conditional mutagenesisThe ORF of cdpk1 is removed in the sporozoite stage by the Flp/FRT system
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameFlpL recombinase of yeast (FlpL)
Details of the genetic modification
Inducable system usedFlp/FRT
Additional remarks inducable system The mutant expresses the yeast FlpL recombinase under the control of the promoter of trap. The mutant does not contain a selectable marker. This marker (the hdhfr gene) has been removed from the genome by using the Flp/FRT site-specific recombination (SSR) system. Removal of the hdhfr gene has been achieved by transmission of the mutant through mosquitoes, thereby activating expression of the FlpL recombinase that resulted in the excision of the hdhfr gene that was flanked by FRT sequences.
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe FlpL coding sequence was flanked by 1.5 kb and 0.6 kb of 5′ and 3′ regulatory sequences of trap, respectively, and associated with a FRTed hdhfr selectable marker containing its own (eef1a) promoter and terminator sequences.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1349800
Gene Model P. falciparum ortholog PF3D7_1335900
Gene productthrombospondin-related anonymous protein | sporozoite surface protein 2
Gene product: Alternative nameTRAP; SSP2; SSP-2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1349800
Gene productsporozoite surface protein 2 thrombospondin-related anonymous protein
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1ATGGTACCATGA-CATCATTTATAAATCATG
Additional information primer 1P1 (KpnI); 230p targeting region
Sequence Primer 2ATACTGCAGTGTGTTTTATTTGGATGTGC
Additional information primer 2P2 (PstI); 230p targeting region
Sequence Primer 3TTGGGCCCTTCTCTTGAGCCCGTTAAT
Additional information primer 3P3 (ApaI); 230p targeting region
Sequence Primer 4TTGGGCCCTAGGAAATTTGTTTATTTTTATA
Additional information primer 4P4 (ApaI); 230p targeting region